News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Cathy Eng: Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer
Cathy Eng/X
Apr 5, 2025, 05:21

Cathy Eng: Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer

Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, posted on X about recent paper she and colleagues co-authored:

“Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2.”

Authors: Cathy Eng, Arvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, Elena Elez, Takayuki Yoshino, Alberto Sobrero, James Yao, Pilar Garcia-Alfonso, Judit Kocsis, Antonio Cubillo Gracian, Andrea Sartore-Bianchi, Taroh Satoh, Violaine Randrian, Jiri Tomasek, Geoff Chong, Zhao Yang, Ferdinand Guevara, William Schelman, Rajash Pallai, Josep Tabernero

Cathy Eng: Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer

Alberto Sobrero Arvind Dasari cancer Cathy Eng colorectal cancer Elena Elez Ferdinand Guevara FRESCO-2 Fruquintinib James Yao Josep Tabernero OncoDaily Oncology Rajash Pallai Rocio Garcia-Carbonero Sara Lonardi Takayuki Yoshino William Schelman Zhao Yang
Special Coverage
Career
May 29, 2025, 21:29
Sendurai Mani: Honored to Receive the Master of Arts Degree from Brown University
Blog
May 29, 2025, 21:17
SPCC on Interview with Aleksandra Filipovic and Ellen Langer About Scientifically Proven Connection Between Mindset and Health
Blog
May 29, 2025, 21:09
Sebastian Szmit: Great Pleasure to Work in SERENITY Study by European Commission
Blog
May 29, 2025, 20:53
Jasmine Kamboj Congratulated Jonathan Ticku for FDA ODAC Testimony on Daratumumab
Opinion
May 29, 2025, 20:33
Zainab Shinkafi-Bagudu Reflects on Access, Staffing, and Policy Ahead of AMCE Launch in Nigeria
Blog
May 29, 2025, 19:20
Diego A. Díaz García: sq-NSCLC Data Shows Benmelstobart Plus Chemo as Promising New 1L Option
Positive
May 29, 2025, 19:09
Excited to Announce the 2025 Board of Directors - IASLC
Career
May 29, 2025, 19:02
Vincent Rajkumar: Thrilled Saad Usmani Will Receive the Giants of Cancer Care Award for Myeloma
Blog
May 29, 2025, 18:50
Narjust Florez: A Few Things I Wish I Knew as a Fellow While Starting the ASCO Journey
Science
May 29, 2025, 18:39
Melvin Chua: Progress in Focal Therapy for Prostate Cancer Can Be Made by Good Science
Blog
May 29, 2025, 18:26
Bench To Bedside on Drug Development for Rare and Economically Infeasible Cancers - FDA Oncology
Career
May 29, 2025, 18:16
The First 2025 Mentor of the Year Nominee: Mariana Chavez Mac Gregor - WinC - AlinC